Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Operating Grant

Sunnybrook Research Institute (Toronto, Ontario)

$77,402.00

Correlation of cortical perfusion and neurocognition between Multiple Sclerosis subtypes using a novel quantitative perfusion sequence

EF 2012-13

Résumé
Disease of the outer layer of the brain or cortex is a previously unrecognized but important cause of both physical and mental disability in Multiple sclerosis (MS). Sparse information exists on the role of the cortex in affecting the ability to think, organize and process information. These skills are critical for social and intellectual functioning and are commonly affected in MS leading to mental disability or cognitive impairment. MRI can directly measure cortical lesions but this is very challenging because the lesions are often very small or difficult to see. This limitation is important because doctors need a reliable and commonly available method to monitor cortical disease so that they can study the effect of cortical lesions on disability. We previously show that a new MRI scan technique (or Bookend perfusion) can measure differences in the cortex between patients with and without cognitive impairment. We think the ability to show differences indirectly reflects differences in cortical disease. We found that cortical abnormality localized to expected brain regions and better predicted cognitive impairment than traditional markers including white matter disease and cortical atrophy. Importantly, we showed strong associations between abnormality and specific cognitive tests associated with information processing speed. The present proposal hopes to expand our study to less affected MS patients (or relapsing remitting MS) to determine whether similar findings are present and allow comparison between MS subtypes. This will test the relationship between disease severity, cognitive impairment and cortical abnormality. We will also assess whether similar spatial differences are seen. The study is important because our new technique is easy to use and may be performed on any MRI scanner allowing routine cortical assessment for all MS patients. The future hope is that the technique can help doctors monitor disease activity and assess the efficacy of new drugs.
Programme
Operating Grant
Emplacement
Ontario, Canada
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
277828
Name
Aviv Richard
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Clinical
Prcname2
Behavioural Sciences - B: Clinical Behavioural Sciences
Projecttitle
Correlation of cortical perfusion and neurocognition between Multiple Sclerosis subtypes using a novel quantitative perfusion sequence
Programtype2
Operating Grants
Orgnameinp2
Sunnybrook Research Institute (Toronto, Ontario)
Cihramount2
$77,402
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Cognitive Dysfunction; Mri Pefusion; Relapsing Remitting Multiple Sclerosis; Secondary Progressive Multiple Sclerosis
Abstract
Disease of the outer layer of the brain or cortex is a previously unrecognized but important cause of both physical and mental disability in Multiple sclerosis (MS). Sparse information exists on the role of the cortex in affecting the ability to think, organize and process information. These skills are critical for social and intellectual functioning and are commonly affected in MS leading to mental disability or cognitive impairment. MRI can directly measure cortical lesions but this is very challenging because the lesions are often very small or difficult to see. This limitation is important because doctors need a reliable and commonly available method to monitor cortical disease so that they can study the effect of cortical lesions on disability. We previously show that a new MRI scan technique (or Bookend perfusion) can measure differences in the cortex between patients with and without cognitive impairment. We think the ability to show differences indirectly reflects differences in cortical disease. We found that cortical abnormality localized to expected brain regions and better predicted cognitive impairment than traditional markers including white matter disease and cortical atrophy. Importantly, we showed strong associations between abnormality and specific cognitive tests associated with information processing speed. The present proposal hopes to expand our study to less affected MS patients (or relapsing remitting MS) to determine whether similar findings are present and allow comparison between MS subtypes. This will test the relationship between disease severity, cognitive impairment and cortical abnormality. We will also assess whether similar spatial differences are seen. The study is important because our new technique is easy to use and may be performed on any MRI scanner allowing routine cortical assessment for all MS patients. The future hope is that the technique can help doctors monitor disease activity and assess the efficacy of new drugs.
Competitiondate
201303
Approvedterm2
1 yr 0 mth
Pinamesdelim
Aviv, Richard
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $77,402~ $0~